| (Values in U.S. Thousands) | Jun, 2019 | Jun, 2018 | Jun, 2017 | Jun, 2016 | Jun, 2015 |
| Sales | 5,510 | 1,280 | 890 | 730 | 2,300 |
| Sales Growth | +330.47% | +43.82% | +21.92% | -68.26% | -6.50% |
| Net Income | -24,750 | -12,810 | -8,680 | -7,480 | -5,950 |
| Net Income Growth | -93.21% | -47.58% | -16.04% | -25.71% | -26.06% |
Avita Medical (AVMXY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Avita Medical Limited operates as a medical technology company. The company develops and distributes products in Regenerative and Respiratory Medicine. Avita's regenerative and tissue-engineered products provide revolutionary solutions utilizing the patient's own skin and the regenerative capability of the human body to treat a wide range of wounds, scars and skin defects. The Company's lead product, ReCell(R) Spray'On Skin (R), is used in a wide variety of burns, plastic, reconstructive and cosmetic procedures. It manufactures and sells a range of spacers for the paediatric, adolescent and adult market. Avita Medical Limited is headquartered in Cambridge, the United Kingdom.